Investment Rating - The investment rating for the company is "Buy-A" with a target price of 61.06 CNY, maintaining the rating [5][12]. Core Views - The company reported a revenue of 2.929 billion CNY for 2024, a year-on-year increase of 6.25%, while the net profit attributable to shareholders was 388 million CNY, a decrease of 11.65% [1]. - The acquisition of Hubei Sibao is expected to enhance the brand value and market share of the company's products, particularly the "Jieting" brand [3]. - The company is focusing on expanding its overseas market presence, particularly in Thailand, through a multi-channel strategy [3]. Financial Performance - In 2024, the company achieved revenues of 2.060 billion CNY from baby hygiene products, 0.552 billion CNY from adult hygiene products, and 0.232 billion CNY from other products, with respective year-on-year growth rates of 4.3%, -0.5%, and 57.6% [2]. - The gross margin for 2024 was 27.91%, an increase of 0.97 percentage points year-on-year, while the net margin was 13.23%, a decrease of 2.68 percentage points [11]. - The company expects revenues to grow to 3.921 billion CNY in 2025, representing a year-on-year growth of 33.84% [12]. Market Strategy - The company plans to leverage its production bases across China to enhance production efficiency and reduce logistics costs [3]. - The strategy includes deepening the local market presence in Thailand and expanding into surrounding countries [3]. Future Projections - The projected net profit for 2025 is 496 million CNY, with a year-on-year growth of 27.95% [12]. - The company anticipates a steady increase in revenue and profit over the next few years, with expected revenues of 4.392 billion CNY in 2026 and 4.969 billion CNY in 2027 [12].